Skip to main content
Fig. 2 | BMC Anesthesiology

Fig. 2

From: Effects of continuous infusion of phenylephrine vs. norepinephrine on parturients and fetuses under LiDCOrapid monitoring: a randomized, double-blind, placebo-controlled study

Fig. 2

Hemodynamic parameters. a Stroke volume (SV), cardiac output (CO), and systemic vascular resistance (SVR) by LiDICOrapid monitoring at the 10 time points. Post hoc Bonferroni correction was performed for within- versus between-subject comparisons. Data are expressed as mean ± standard deviation. *0.25 μg/kg/min phenylephrine vs. control group, P < 0.05; #0.05 μg/kg/min norepinephrine vs. control group, P < 0.05; †0.25 μg/kg/min phenylephrine vs. 0.05 μg/kg/min norepinephrine group, P < 0.05. b Fluctuations in heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) during operation at 10 time points. Markers are means, and error bars are standard deviation. *statistical significance between the 0.25 μg/kg/min phenylephrine and control groups; #statistical significance between 0.05 μg/kg/min norepinephrine group and control groups; statistical significance between 0.25 μg/kg/min phenylephrine and 0.05 μg/kg/min norepinephrine groups. Post hoc Bonferroni correction was performed for within- versus between-subject comparisons

Back to article page